Cas No.: | 1313498-08-6 |
名称: | (S)-5-(3-(tert-butyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-3-(4-fluorophenyl)-1,2,4-oxadiazole, 5-[(7S)-3-tert-butyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-7-yl]-3-(4-fluorophenyl)-1,2,4-oxadiazole |
别名: | LSN2814617 |
SMILES: | C(C1N=C([C@]([H])2CC3=NN=C(C(C)(C)C)N3CC2)ON=1)1=CC=C(F)C=C1 |
分子式: | C18H20FN5O |
分子量: | 341.382 |
纯度: | |
保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | |
In Vivo: | |
In Vitro: | |
References: | LSN2814617 is a neurotoxic positive allosteric modulator. For the detailed information of LSN2814617, the solubility of LSN2814617 in water, the solubility of LSN2814617 in DMSO, the solubility of LSN2814617 in PBS buffer, the animal experiment (test) of |
Kinase Assay: | |
Cell Assay: | |
Animal Administration: | |
References: |